A „Tüdőgyógyászati, Allergológiai és Immunológiai Megbetegedések” (TAIM) Nemzetközi Alapítvány XIV. Szakmai Továbbképzése 2019. augusztus 29–30. között kerül megrendezésre a Debreceni Egyetem ÁOK, Elméleti Tömbjében.

A pályamunkák beküldési határideje: 2019. július 20.  

Pályamunka felhívás
Regisztráció
Információk
Program

A továbbképzés fő témái:

Tüdőgyógyászat:
Asthma bronchiale / Allergenspecifikus immunterápia / COPD /Immunpatogenezisű tüdőbetegségek / Tüdőfibrosis / Légzésrehabilitáció / Bronchologia / Lélegeztetés tüdőgyógyászati intenzív osztályon

Tumorimmunologia/Immunterápia tüdődaganatokban

Bőrgyógyászat/Dermatitisek

Belgyógyászat /Onkokardiologia

Immunológia/ Sebészet/ Fül-Orr-Gégészet,

Fogászati allergológia

AKKREDITÁCIÓ:

A továbbképzés akkreditált: 32 kreditpont.

Akkreditáció száma: DE ÁOK/2019.II/00105
A továbbképzés tesztírással zárul.

Kötelezően választható tanfolyam az alábbi szakmák dolgozóinak:

• tüdőgyógyászat
• allergológia és klinikai immunológia
• bőrgyógyászat
• fül-orr-gégészet
• gyermektüdőgyógyászat
• reumatológia
• háziorvostan
• immunológia (elméleti)

Szeretettel várjuk Debrecenben, a TAIM XIV. Továbbképzésén!

Dr. Varga Imre PhD
a TAIM Kuratóriumának elnöke
a Szervező Bizottság elnöke

Dear Colleagues,

We are pleased to inform you that the 24th WorldLab Congress in Seoul will be held jointly with the 16th APFCB (Asia-Pacific Federation of Clinical Biochemistry) Congress in June 2022.

The IFCC and APFCB have agreed that a joint conference would be more attractive and beneficial for both conference delegates and corporate sponsors and will ensure wider participation from laboratory professionals and industry partners across Asia-Pacific and around the world.

The host Society, the Korean Society for Clinical Chemistry (KSCC) has also very graciously agreed to host the joint WorldLab-APFCB Congress in Seoul which has also been approved by the IFCC and APFCB Executive Boards.

The Joint WorldLab-APFCB Congress will be held on 26th -30th June 2022 in Seoul at the Coex Convention and Exhibition Center.

We welcome all IFCC national societies and corporate member to actively participate in this major and exciting event next year.

Your sincerely

Prof. Khosrow Adeli
IFCC President

Dear Colleagues,

We are pleased to inform you that the 24th WorldLab Congress in Seoul will be held jointly with the 16th APFCB (Asia-Pacific Federation of Clinical Biochemistry) Congress in June 2022.

The IFCC and APFCB have agreed that a joint conference would be more attractive and beneficial for both conference delegates and corporate sponsors and will ensure wider participation from laboratory professionals and industry partners across Asia-Pacific and around the world.

The host Society, the Korean Society for Clinical Chemistry (KSCC) has also very graciously agreed to host the joint WorldLab-APFCB Congress in Seoul which has also been approved by the IFCC and APFCB Executive Boards.

The Joint WorldLab-APFCB Congress will be held on 26th -30th June 2022 in Seoul at the Coex Convention and Exhibition Center.

We welcome all IFCC national societies and corporate member to actively participate in this major and exciting event next year.

Your sincerely

Prof. Khosrow Adeli
IFCC President

Absztrakt beküldés: 2022. április 11-ig. >> Kedvezményes regisztráció február 28-ig.

Abstract submission platform is opened since October 14th, 2021. You have until January 7th, 2022 at 23:59 CET to submit. Do it now!
Abstract submission opening: October 14th 2021  Abstract submission deadline: January 7th 2022  Registration opening: March 1st 2022  Early registration fee deadline: April 1st 2022     More information

Every three years, the SPIN Congress gathers some 1,500 delegates from around 90 countries. It is the major international meeting focused on the patient management and therapeutic strategies with a special emphasis on the daily medical practice. Experts throughout the entire world report on their experiences and deliver insight into the latest results and clinical studies.

SPIN 2022 will offer a holistic view of the inflammatory skin diseases, particularly focused on psoriasis, atopic dermatitis, vitiligo, alopecia, and hidradenitis suppurativa; including teaching, sharing, and understanding of the different scenarios around the world, keeping in mind the perspective of the patients. The congress will be in a hybrid format, thus enabling participants to attend physically or online. Besides, it will offer a dynamic, interdisciplinary and interactive programme.